Latest News

Non-invasive first trimester blood test reliably detects Down's syndrome and other genetic fetal abnormalities

New research has found that routine screening using a non-invasive test that analyzes fetal DNA in a pregnant woman's blood can accurately detect Down's syndrome and other genetic fetal abnormalities in the first trimester. The results suggest that the test is superior to currently available screening strategies and could reshape standards in prenatal testing.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Safer alternatives to nonsteroidal antinflamatory pain killers

  • Mystery behind general anesthetic action becoming more clear

  • Narrowing of neck artery without warning may signal memory, thinking decline

  • Sleep behavior disorder linked to brain disease

  • Suicide rates soar in Greece as economic cuts hurt citizens

  • Single motherhood does not make women unhappy, study reports

  • New drugs offer hope for migraine prevention

  • Quality improvement program helps lower risk of bleeding, death following stroke

  • Conservative management of vascular abnormality in brain associated with better outcomes

  • Patient preferences for emergency treatment of stroke examined in new study

  •